Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001551163-15-000098
Filing Date
2015-04-15
Accepted
2015-04-15 16:29:37
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 f10kdec312014vedgar5.htm 10-K 528860
3 sgadd.jpg GRAPHIC 37285
4 exhibit31.htm EX-31 7420
5 exhibit32.htm EX-32 4095
  Complete submission text file 0001551163-15-000098.txt   1469126

Data Files

Seq Description Document Type Size
6 prtt-20141231.xml EX-101.INS 116134
7 prtt-20141231.xsd EX-101.SCH 10194
8 prtt-20141231_cal.xml EX-101.CAL 11488
9 prtt-20141231_def.xml EX-101.DEF 14271
10 prtt-20141231_lab.xml EX-101.LAB 66740
11 prtt-20141231_pre.xml EX-101.PRE 54905
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

EIN.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54001 | Film No.: 15771962
SIC: 2834 Pharmaceutical Preparations